Monitoring the Expression Profiles of Doxorubicin-Resistant K562 Human Leukemia Cells by Serial Analysis of Gene Expression

International Journal of Hematology

Volumn 79, Issue 3, 2004, Pages 276-282

  Ichikawa, Yoshikazu ^a   Hirokawa, Makoto ^a   Aiba, Namiko ^a   Fujishima, Naohito ^a   Komatsuda, Atsushi ^a   Saitoh, Hirobumi ^a   Kume, Masaaki ^a   Miura, Ikuo ^a   Sawada, Ken Ichi ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Doxorubicin; Expression profile; K562; Resistance; SAGE

Indexed keywords

ACYL COENZYME A DESATURASE; CELL PROTEIN; COMPLEMENTARY DNA; DOXORUBICIN; ETOPOSIDE; HEAT SHOCK PROTEIN 90; HEMOGLOBIN A2; HEMOGLOBIN E; INITIATION FACTOR 1A; IRON SULFUR PROTEIN; KARYOPHERIN BETA; KARYOPHERIN BETA1; LAMININ RECEPTOR; LAMININ RECEPTOR 1; PROTEIN N MYRISTOYLTRANSFERASE; PROTEIN RAD23; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; RNA BINDING PROTEIN; SPECTRIN; SPECTRIN B; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; CELL STRAIN K 562; COMPUTER ANALYSIS; COMPUTER PROGRAM; DNA MICROARRAY; GENE CLUSTER; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SERIAL ANALYSIS OF GENE EXPRESSION;

EID: 2442614166     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.03133     Document Type: Article

References (23)

1. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell. 1994;78:539-542.
2. Kawabata Y, Hirokawa M, Kitabayashi A, Horiuchi T, Kuroki J, Miura AB. Defective apoptotic signal transduction pathway downstream of caspase-3 in human B lymphoma cells: a novel mechanism of nuclear apoptosis resistance. Blood. 1999;94:3523-3530.
3. Dalton WS. Mechanisms of drug resistance in hematologic malignancies. Semin Hematol. 1997;34(suppl 5):3-8.
4. Hirokawa M, Kawabata Y, Miura AB. Dysregulation of apoptosis and a novel mechanism of defective apoptotic signal transduction in human B-cell neoplasms. Leuk Lymphoma. 2002;43:243-249.
5. Kudoh K, Ramanna M, Ravatn R, et al. Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray. Cancer Res. 2000;60:4161-4166.
6. Turton NJ, Judah DJ, Riley J, et al. Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance. Oncogene. 2001;20:1300-1306.
7. Sakamoto M, Kondo A, Kawasaki K, et al. Analysis of gene expression profiles associated with cisplatin resistance in human ovarian cancer cell lines and tissues using cDNA microarray. Hum Cell. 2001;14:305-315.
8. Zembutsu H, Ohnishi Y, Tsunoda T, et al. Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs. Cancer Res. 2002;62:518-527.
9. Kihara C, Tsunoda T, Tanaka T, et al. Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res. 2001;61: 6474-6479.
10. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science. 1995;270:484-487.
11. Tsuruo T, Saito HI, Kawabata H, Oh-hara T, Hamada H, Utakoji T. Characteristics of resistance to Adriamycin in human myelogenous leukemia K562 resistant to Adriamycin and in isolated clones. Jpn J Cancer Res. 1986;77:682-692.
12. Sugimoto Y, Tsuruo T. DNA-mediated transfer and cloning of a human multidrug-resistant gene of Adriamycin-resistant myelogenous leukemia K562. Cancer Res. 1987;47:2620-2625.
13. Naito M, Tsuruo T. Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium ion involvement. Cancer Res. 1989;49:1452-1455.
14. Sugawara I, Iwahashi T, Okamoto K, et al. Characterization of an etoposide-resistant human K562 cell line, K/eto. Jpn J Cancer Res. 1991;82:1035-1043.
15. Batty D, Rapic'-Otrin V, Levine AS, Wood RD. Stable binding of human XPC complex to irradiated DNA confers strong discrimination for damaged sites. J Mol Biol. 2000;300:275-290.
16. Sugasawa K, Ng JM, Masutani C, et al. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell. 1998;2:223-232.
17. Volker M, Mone MJ, Karmakar P, et al. Sequential assembly of the nucleotide excision repair factors in vivo. Mol Cell. 2001;8: 213-224.
18. Tewely KM, Rowe TC, Yang L, Halligan BD, Liu LF. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science. 1984;226:466-468.
19. Yow HK, Wong JM, Chen HS, et al. Increased mRNA expression of a laminin-binding protein in human colon carcinoma: complete sequence of a full-length cDNA encoding the protein. Proc Natl Acad Sci U S A. 1988;85:6394-6398.
20. Damiano JS, Hazlehurst LA, Dalton WS. Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation. Leukemia. 2001;15: 1232-1239.
21. Shi Y, Zhai H, Wang X, et al. Multidrug-resistance-associated protein MGr1-Ag is identical to the human 37-kDa laminin receptor precursor. Cell Mol Life Sci. 2002;59:1577-1583.
22. Marquardt A, Stohr H, White K, Weber BHF. cDNA cloning, genomic structure, and chromosomal location of three members of the human fatty acid desaturase family. Genomics. 2000;66:175-183.
23. Marzo I, Martinez-Lorenzo MJ, Anel A, et al. Biosynthesis of unsaturated fatty acids in the main cell lineages of human leukemia and lymphoma. Biochim Biophys Acta. 1995;1257:140-148.